goldfinger
- 18 Oct 2013 16:20
- 1082 of 2763
Long KGF. Chart looks oversold and volume of buys to sells is convincing for the bull case. Fundys solid, plenty of cash. Self help scheme.
skinny
- 18 Oct 2013 16:21
- 1083 of 2763
ATP - post 1071 at a key area atm.
Chris Carson
- 18 Oct 2013 16:22
- 1084 of 2763
Looking good GF, on my watch list.
goldfinger
- 18 Oct 2013 17:02
- 1086 of 2763
Go back to page 51 Skinny and all, we have really wassed the market. Just 1 or 2 down but you cant get them all right.
Well done to all.
goldfinger
- 19 Oct 2013 10:46
- 1087 of 2763
The week ahead...
By Julie Fisher | Fri, 18th October 2013 - 17:08
A busy week for corporate news sees reports from tobacco firm British American Tobacco and pharmaceuticals giant GlaxoSmithKline.
Monday 21 October
Trading statements
Senior.
AGM/EGM
Univision Engineering, Renewable Energy Holdings.
--------------------------------------------------------------------------------
Tuesday 22 October
After a quiet Monday, publican Spirit Pub Company (SPRT) will announce its full-year results on Tuesday.
Analysts' expectations: "The trading update should show further progress in both managed and leased pubs and we forecast 1% like-for-like sales growth in managed pubs and 0.5% like-for-like net income growth in leased pubs," comments Panmure Gordon analyst Lindsey Kerrigan.
She reiterates her 'buy' rating, adding: "The stock is the least expensive amongst the pub and restaurant companies."
Valuation: Spirit trades on a 2014 enterprise value/EBITDAR ratio of between seven and eight times.
Economic news
On the economic front, the public finance net borrowing data for September will be released on Tuesday. The deficit stood at £13.2 billion in August.
"With the economic recovery in train, we expect borrowing in September to see a fall on its level a year earlier," economists at Capital Economics predict.
"September's figures will reflect the £3.2 billion raised from the government's recent sale of part of its stake in Lloyds. But generally, privatisation proceeds are regarded as a financial transaction, reducing public sector net debt and the cash requirement, but not net borrowing."
They forecast a deficit of £10.6 billion, down from £12.1 billion in September 2012.
Trading statements
Telekomunikacja Polska, Whitbread, Eurasia Drilling Company, ARM Holdings, B.P. Marsh & Partners, Spirit Pub, Epistem Holdings, UBM, Reckitt Benckiser, Petropavlovsk, GKN.
AGM/EGM
JSC KazMunaiGas Exploration Production, Diverse Income Trust, Aberforth Geared Income Trust PLC.
--------------------------------------------------------------------------------
Wednesday 23 October
Online retailer ASOS (ASC) will report its full-year results on Wednesday.
Recent news: Fourth-quarter revenue beat consensus forecasts of £204.3 million, rising 46% to £212.5 million, while UK sales increased 49% to £74.1 million, also beating the consensus estimate of £67.5 million.
Analysts' expectations: "Following a better-than-anticipated fourth quarter, consensus forecasts have moved up to £53.7 million in pre-tax profit and we forecast £53.1 million pre-tax profit," says Pamure Gordon analyst Simon French.
He rates ASOS a 'buy' and warns investors that the valuation may not be entirely reliable, commenting: "Given the high growth and significant market opportunity we think static valuation measures are of limited use."
Valuation: The stock trades on a 2014 price/earnings (P/E) of between 67 and 68 times.
This will be followed by third-quarter results from pharmaceuticals giant GlaxoSmithKline (GSK).
Analysts' expectations: Panmure Gordon's Savvas Neophytou forecasts a 0.8% decline in group revenues to £6.47 billion, operating profit of £1.85 billion, pre-tax profit of £1.69 billion and adjusted earnings per share of 24.7p, all slightly below consensus.
But he still rates the stock a 'buy' commenting that "it is not contentious to say that GlaxoSmithKline has the best respiratory pipeline" in the business, which "should provide mitigation to increased risk to the company's biggest product Adivair", which currently represents around 25% of the company's profits.
"Valuation is now undemanding, trading in line with the sector, and does not fully capture the value of the pipeline," he concludes.
"The company has been through the majority of its patent expiries, big liability settlements and boasts a strong balance sheet and very little M&A risk."
Valuation: GlaxoSmithKline is trading on a 2013 P/E ratio of almost 14 times.
Economic news
October's monetary policy committee (MPC) meeting minutes will be published on Wednesday, and economists from Capital Economics expect the meeting to have been "uneventful".
"With the turbulence surrounding the introduction of forward guidance having eased and no pressing case for either a tightening or loosening of monetary policy, the minutes are likely to show relative harmony among committee members," they comment.
"With September's minutes showing that the dovish David Miles and Paul Fisher dropped their support for more quantitative easing, October will almost certainly see another month of unanimity among the MPC in support of no change in policy."
Trading statements
Home Retail Group, GlaxoSmithKline, Norsk Hydro, ASOS, Sports Direct International, Laird, British American Tobacco, Mecom Group, International Personal Finance, Computacenter.
AGM/EGM
Arcontech Group, Haynes Publishing Group, MTI Wireless Edge.
--------------------------------------------------------------------------------
Thursday 24 October
Thursday will open with a third-quarter statement from life insurer St. James's Place (SJP3).
Analysts' expectations: "We expect the continued recovery in equity markets to have had a positive impact on sales in the period," comments Panmure Gordon analyst Barrie Comes.
He forecasts third-quarter sales at £206.2 million annual premium equivalent (APE), up 24.5% on the equivalent period of 2012, and sales for the year to date at £632.7 million APE.
"The shares have performed well but since August have merely performed in line with the wider market," he adds.
"We believe that with strong sales growth forecast and a positive outlook for equities the shares are undervalued and that the current share price represents an excellent buying opportunity."
St James's Place is Panmure's top pick for the fourth quarter among the larger UK life insurers.
Valuation: The stock is trading on a P/E ratio of almost 20 times.
Another third-quarter statement will follow from British American Tobacco (BATS).
Analysts' expectations: "We forecast a volume decline of 3.1% to 501 billion sticks and positive pricing variance of 6.9% resulting in organic revenue growth of 3.8% for the nine months to 30 September," comments Panmure Gordon's Damien McNeela.
"We continue to see the combination of British American's strong cash generation, high shareholder returns and valuation as attractive."
He has a 'buy' rating on the stock.
Valuation: British American trades on a P/E ratio of just over 14 times.
Economic news
The CBI is to publish the results of its industrial trends survey for October and the third quarter on Thursday.
"We expect the total orders balance of the CBI survey to edge down but to still be consistent with strong growth in manufacturing output," the Capital Economics economists comment, forecasting a fall from +9 to +5.
"Meanwhile, the quarterly business optimism balance seems likely to improve. Various measures of consumer confidence have risen recently. And the monthly output expectations balance rose sharply in the first two months of the third quarter to a level which, on the basis of past form, suggests the business optimism balance rose from +7 to around +20."
Trading statements
Stobart Group, Bloomsbury Publishing, ICON, Unilever, Shire, Tracsis, Avacta Group, Debenhams, The Go-Ahead Group, AZ Electronic Materials, WPP Group, St James's Place, Segro, Kazakhmys, International Ferro Metals, Inchcape.
AGM/EGM
Murgitroyd Group, BHP Billiton, Rangers International Football Club, Thorntons, The Go-Ahead Group, Lucky Cement, Queenco Leisure International.
--------------------------------------------------------------------------------
Friday 25 October
Economic news
Despite being a quiet day for company news, Friday will see some important economic news, with the preliminary estimate of gross domestic product (GDP) for the third-quarter, being released.
In the second quarter GDP rose by 0.7% and economists from Capital Economics expect that "output expanded at a healthy, albeit not stellar, rate" in the third quarter.
"Many of the business surveys point to quarterly GDP growth of more than 1%. But the official data that we have had so far have been a bit softer," the economists say.
Industrial production and construction output are expected to add just 0.1% each to GDP, while services output could add 0.5%.
"So, while a range of figures are possible, GDP growth of about 0.7% seems plausible. While this would disappoint hopes that the recovery has sped up, it would still be a good result given that real pay is falling and the fiscal squeeze remains tight."
Trading statements
SVG Capital, APR Energy.
AGM/EGM
Galleon Holdings, Daily Internet, Murray Income Trust, Hargreaves Lansdown
goldfinger
- 19 Oct 2013 13:55
- 1088 of 2763
Plexus at above 230p the target is 350p
By The Closet Chartist — Friday 18 October 2013
Share this article with your comrades in revolutionary capitalism
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Some traders looking at the daily chart of Plexus (POS) might be getting a sinking feeling in terms of what the price action has been doing over the past three months in terms of the extended consolidation. But…
This has taken place for the share price roughly 20p either side of the 250p level, although so far well above the 200 day moving average at 231p.
So while there is no end of day close back below the 200 day line we can assume that the stock is merely delivering an extended bull flag, a formation that should be resolved to the upside.
Perhaps even better than this prediction is the way that despite recent attempts to probe to the downside the shares have been able to remain well above the floor of a July unfilled gap to the downside at 229p.
The lowest the shares have been able to dip since then is September’s 236p low, before this month they put in a higher low at 243p.
All this adds up to the prospect of Plexus now being ready to resume the break to the upside which has been on the cards since the triple unfilled gaps to the upside of July.
The implication is that while the 200 day line holds we could be due a top of July price channel target as high as 350p in terms of being a modest end of year target.
free stock charts from uk.advfn.com
dreamcatcher
- 19 Oct 2013 17:29
- 1089 of 2763
Still hold Plexus g. Really for the news of the big industry players developing a deep well head along with Plexus, which will transform the company. A P/E Ratio of 87.29 :-))
goldfinger
- 19 Oct 2013 19:56
- 1090 of 2763
Gosh with a P/E that high Im not suprised its stalled. Any idea what forward P/Es are?DC
dreamcatcher
- 19 Oct 2013 20:08
- 1091 of 2763
Why did you ask g ? I have looked it up -
Definition of 'Forward Price To Earnings - Forward P/E'
A measure of the price-to-earnings ratio (P/E) using forecasted earnings for the P/E calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Forward Price To Earnings (Forward P/E)
Also referred to as "estimated price to earnings".
'Forward Price To Earnings - Forward P/E'
The estimated P/E of a company is often used to compare current earnings to estimated future earnings. If earnings are expected to grow in the future, the estimated P/E will be lower than the current P/E. This measure is also used to compare one company to another with a forward-looking focus.
goldfinger
- 19 Oct 2013 20:36
- 1092 of 2763
No I meant whats the concensus brokers P/E targets for 2014 and 2015? Surely it must come down a long way.
Sorry im on the lap top at moment and havent got the sites saved that I have on the PCs.
Closet chartist is Zak Mir by the way Winnies mate.
goldfinger
- 20 Oct 2013 20:03
- 1093 of 2763
cynic
- 20 Oct 2013 21:03
- 1094 of 2763
ah synthomer ..... have never followed their shares tho we do a lot of biz with them indirectly
goldfinger
- 20 Oct 2013 21:16
- 1095 of 2763
NO nit, prudential.
Always thought you liked this one. Just look at that gap and the volume on friday.
cynic
- 20 Oct 2013 21:57
- 1096 of 2763
crikey .... didn't even notice and it's certainly one i have watched for ages
in fact, i thought you were having a little tease about unite and its homonymous union alter ego :-)
goldfinger
- 20 Oct 2013 22:00
- 1097 of 2763
LOL no. I knew you liked the PRU and my system spat it out friday night so I went to the chart and thought straight away cyners will like the look of that.
skinny
- 21 Oct 2013 14:53
- 1098 of 2763
KCOM - post 1066 toying with a quid.
ATP - post 1070 at all time high.